Katalysts - A Podcast by Katalyze AI

In This Episode In this episode, Reza Farahani, the Founder and CEO of Katalyze AI, unveils how blending artificial intelligence with biomanufacturing is set to disrupt drug production, lower costs, and democratize biotech innovation. Get ready for an in-depth conversation on the evolution, challenges, and future of bio-manufacturing.  Reza Farahani is the CEO and Founder of Katalyze AI, an AI-dri...

In This Episode In this episode, we dive deep into the real impact of AI with Ramila Peiris. He shares how businesses can effectively adopt AI by investing in people, fostering collaboration, and creating sustainable data strategies. Whether you're an AI enthusiast, business leader, or just curious about the future of data, this conversation is packed with valuable insights. Ramila Peiris is Globa...

In This Episode In this episode, we dive deep into how AI is reshaping the pharmaceutical manufacturing landscape with Harini Gopalakrishnan. From improving operational efficiency to leveraging predictive analytics and generative content, Harini shares her expertise on driving smarter, faster, and more accurate decisions in this critical industry.  Harini Gopalakrishnan is a seasoned professional...

In This Episode In this episode, Lee Bowman, COO of Mediphage, explores the intersection of gene therapy, AI, and digital transformation in biotech. With a strong focus on operational excellence, he leads cross-functional teams, manages budgets, and fosters key stakeholder relationships to drive groundbreaking gene therapy technologies. Bowman discusses how innovation is accelerating drug developm...

In This Episode This episode of Katalysts by Katalyze AI dives deep into the world of artificial intelligence, featuring Paul Kim's insights on its transformative potential across industries. With over 30 years of experience in Washington DC, Paul Kim advises patient advocates, global life science leaders, and innovative emerging companies on FDA and public health policy- developing legislative an...

In This Episode In this episode, Mike Tomasco discusses the integration of generative AI in biopharmaceutical manufacturing, particularly how it can enhance shop-floor operations and improve efficiency. Mike, a former VP of digitization at Pfizer, emphasizes the potential of AI-driven tools like Katalyze AI to simplify complex tasks for operators by acting as a co-pilot. This technology can predic...

In This Episode In this episode of Katalysts, the host interviews Michael (Mike) Burton, an expert in biopharma and drug development, about the industry's evolution, challenges, and the impact of AI on manufacturing processes. Burton discusses his career transition from life sciences operations to health tech, highlighting the increasing complexity and costs of biologics and vaccines compared to s...

In This Episode This episode delves into the transformative role of Katalyze AI in enhancing biopharmaceutical manufacturing. Featuring insights from Mike Tomasco, the discussion explores the implementation of generative AI, including the 'manufacturing copilot', to streamline operations through predictive algorithms and chatbots. Key topics include real-time decision-making, data automation, and...

In This Episode Chris Calabretta discusses the transformative impact of AI on biomanufacturing and pharmaceuticals.  He emphasizes AI's role in managing data overload, enhancing real-time data analysis, and adapting to regulatory changes to improve operational efficiency. Calabretta highlights the importance of talent development in navigating this technological shift, urging companies to invest i...